Envoy Medical Past Earnings Performance
Past criteria checks 0/6
Envoy Medical's earnings have been declining at an average annual rate of -87.8%, while the Medical Equipment industry saw earnings growing at 13.4% annually. Revenues have been growing at an average rate of 33.3% per year.
Key information
-87.8%
Earnings growth rate
-51.5%
EPS growth rate
| Medical Equipment Industry Growth | 8.9% |
| Revenue growth rate | 33.3% |
| Return on equity | n/a |
| Net Margin | -9,464.6% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Envoy Medical makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 0 | -30 | 9 | 9 |
| 30 Sep 23 | 0 | -39 | 7 | 7 |
| 30 Jun 23 | 0 | -40 | 6 | 6 |
| 31 Mar 23 | 0 | -29 | 5 | 5 |
| 31 Dec 22 | 0 | -16 | 3 | 5 |
| 31 Dec 21 | 0 | -9 | 2 | 4 |
Quality Earnings: COCH is currently unprofitable.
Growing Profit Margin: COCH is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if COCH's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Unable to compare COCH's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: COCH is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (6.3%).
Return on Equity
High ROE: COCH's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.